NASDAQ · ITRM

Iterum Therapeutics plc

Healthcare · Biotechnology

$0.03

Down-$0.00 (-10.98%)

Updated Sep 16, 2026, 1:07 PM

SID Score

2.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap: 22.61M
P/E ratio: -0.8
Dividend yield: 0.00%
52-week range: $0.03 – $1.42
Volume: 65.74M
Avg. volume: 962.35K

Price performance

ITRM price history

1M range · 0 trading sessions · Daily adjusted prices

Data unavailable

The requested market data was not found.

Latest ITRM news

The latest Smart Investors Daily articles mentioning ITRM.

earningsAug 3, 2026

Iterum Therapeutics plc (ITRM) Set to Report Q4 Earnings on August 04, 2026

earningsJul 9, 2026

Iterum Therapeutics plc (ITRM) Set to Report Q4 Earnings on July 10, 2026

earningsJun 29, 2026

Iterum Therapeutics plc (ITRM) Set to Report Q4 Earnings on June 30, 2026

Latest ITRM news

The latest Smart Investors Daily articles mentioning ITRM.

Stock researchResearch & News · SEC Filings

Company

Overview Forecast Earnings Dividend Financials

Market Activity

Options Insider Trades Short Interest Institutional Ownership Sentiment

Research & News

Analysis Competitors News SEC Filings SID Coverage

ITRM research

SEC Filings

Recent regulatory filings and source documents.

ITRM SEC filings
Filed	Form	Description	Accepted	Document
Mar 31, 2026	8-K	Form 8-K - Current report - Item 3.01 Item 8.01	—	Open source
Mar 27, 2026	8-K	Form 8-K - Current report - Item 1.03 Item 2.04 Item 5.02 Item 7.01 Item 9.01	—	Open source
Mar 3, 2026	8-K	Form 8-K - Current report - Item 8.01	—	Open source
Mar 2, 2026	8-K	Form 8-K - Current report - Item 3.01	—	Open source
Feb 18, 2026	8-K	Form 8-K - Current report - Item 5.07 Item 8.01	—	Open source
Jan 2, 2026	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Nov 20, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Nov 14, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Nov 14, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Oct 16, 2025	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Sep 10, 2025	8-K	Form 8-K - Current report - Item 5.07	—	Open source
Aug 28, 2025	8-K	Form 8-K - Current report - Item 3.01	—	Open source
Aug 20, 2025	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
Aug 12, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 5, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Aug 5, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Aug 4, 2025	8-K	Form 8-K - Current report - Item 1.01	—	Open source
Jul 28, 2025	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Jul 18, 2025	8-K	Form 8-K - Current report - Item 8.01	—	Open source
Jul 18, 2025	PRE 14A	Form PRE 14A - Other preliminary proxy statements	—	Open source
Jul 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 11, 2025	8-K	Form 8-K - Current report - Item 1.01	—	Open source
May 19, 2025	8-K	Form 8-K - Current report - Item 1.01 Item 2.03 Item 7.01 Item 9.01	—	Open source
May 13, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
May 13, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Apr 29, 2025	8-K	Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01	—	Open source
Mar 10, 2025	8-K	Form 8-K - Current report - Item 5.02 Item 8.01	—	Open source
Feb 14, 2025	8-K	Form 8-K - Current report - Item 3.01 Item 5.02	—	Open source
Feb 7, 2025	S-3	Form S-3 - Registration statement under Securities Act of 1933	—	Open source
Feb 7, 2025	10-K	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	—	Open source
Feb 7, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Jan 23, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Dec 11, 2024	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Nov 21, 2024	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Nov 14, 2024	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Nov 14, 2024	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Nov 1, 2024	8-K	Form 8-K - Current report - Item 2.03 Item 9.01	—	Open source
Oct 25, 2024	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
Oct 15, 2024	8-K	Form 8-K - Current report - Item 3.01	—	Open source
Oct 8, 2024	8-K	Form 8-K - Current report - Item 5.07	—	Open source
Oct 4, 2024	8-K	Form 8-K - Current report - Item 3.01	—	Open source
Aug 14, 2024	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Aug 14, 2024	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Aug 14, 2024	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Aug 12, 2024	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 12, 2024	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 12, 2024	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 6, 2024	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Aug 2, 2024	PRE 14A	Form PRE 14A - Other preliminary proxy statements	—	Open source
Jul 22, 2024	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source

Filed

Form

Description

Accepted

Document

Mar 31, 2026

8-K

Form 8-K - Current report - Item 3.01 Item 8.01

—

Open source

Mar 27, 2026

8-K

Form 8-K - Current report - Item 1.03 Item 2.04 Item 5.02 Item 7.01 Item 9.01

—

Open source

Mar 3, 2026

8-K

Form 8-K - Current report - Item 8.01

—

Open source

Mar 2, 2026

8-K

Form 8-K - Current report - Item 3.01

—

Open source

Feb 18, 2026

8-K

Form 8-K - Current report - Item 5.07 Item 8.01

—

Open source

Jan 2, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Nov 20, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Nov 14, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Nov 14, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Oct 16, 2025

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Sep 10, 2025

8-K

Form 8-K - Current report - Item 5.07

—

Open source

Aug 28, 2025

8-K

Form 8-K - Current report - Item 3.01

—

Open source

Aug 20, 2025

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

Aug 12, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 5, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Aug 5, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Aug 4, 2025

8-K

Form 8-K - Current report - Item 1.01

—

Open source

Jul 28, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Jul 18, 2025

8-K

Form 8-K - Current report - Item 8.01

—

Open source

Jul 18, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

—

Open source

Jul 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 11, 2025

8-K

Form 8-K - Current report - Item 1.01

—

Open source

May 19, 2025

8-K

Form 8-K - Current report - Item 1.01 Item 2.03 Item 7.01 Item 9.01

—

Open source

May 13, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

May 13, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Apr 29, 2025

8-K

Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01

—

Open source

Mar 10, 2025

8-K

Form 8-K - Current report - Item 5.02 Item 8.01

—

Open source

Feb 14, 2025

8-K

Form 8-K - Current report - Item 3.01 Item 5.02

—

Open source

Feb 7, 2025

S-3

Form S-3 - Registration statement under Securities Act of 1933

—

Open source

Feb 7, 2025

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

—

Open source

Feb 7, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Jan 23, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Dec 11, 2024

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Nov 21, 2024

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Nov 14, 2024

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Nov 14, 2024

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Nov 1, 2024

8-K

Form 8-K - Current report - Item 2.03 Item 9.01

—

Open source

Oct 25, 2024

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

Oct 15, 2024

8-K

Form 8-K - Current report - Item 3.01

—

Open source

Oct 8, 2024

8-K

Form 8-K - Current report - Item 5.07

—

Open source

Oct 4, 2024

8-K

Form 8-K - Current report - Item 3.01

—

Open source

Aug 14, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Aug 14, 2024

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Aug 14, 2024

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Aug 12, 2024

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 12, 2024

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 12, 2024

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 6, 2024

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Aug 2, 2024

PRE 14A

Form PRE 14A - Other preliminary proxy statements

—

Open source

Jul 22, 2024

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Iterum Therapeutics plc (ITRM) Set to Report Q4 Earnings on August 04, 2026

Iterum Therapeutics plc (ITRM) Set to Report Q4 Earnings on July 10, 2026

Iterum Therapeutics plc (ITRM) Set to Report Q4 Earnings on June 30, 2026

Featured By

Iterum Therapeutics plc (ITRM) Set to Report Q4 Earnings on August 04, 2026

Iterum Therapeutics plc (ITRM) Set to Report Q4 Earnings on July 10, 2026

Iterum Therapeutics plc (ITRM) Set to Report Q4 Earnings on June 30, 2026